Viratek Inc.: The Costa Mesa pharmaceutical company...
Viratek Inc.: The Costa Mesa pharmaceutical company reported second-quarter earnings of $421,000, contrasted with a loss of $1.7 million in the year-earlier quarter. Revenue was $478,000, up sharply from $7,000 a year earlier. For the first half, earnings totaled $826,000, contrasted with a loss of $1.5 million for the first six months a year earlier. Revenue rose to $1.8 million from $308,000.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.